Saw this one on the NEU thread : https://www.marketwatch.com/story/why-2018-is-a-make-or-break-year-for-pharma-2017-12-19
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game